Home › Atherosclerosis › Kansas › Topeka
Atherosclerosis clinical trials in Topeka, KS
3 studies for Atherosclerosis are looking for participants at sites in and around Topeka (within about 30 miles). Open a study to see who can join and how to contact the study team.
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
RecruitingPhase 3
- Cotton O'Neil Clinical Research Center, Topeka
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
RecruitingPhase 3
- Cotton-ONeil Diabetes and Endocrinology Center, Topeka
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
RecruitingPhase 3
- Research Site, Topeka
About Atherosclerosis
Atherosclerosis is hardening and narrowing of the arteries caused by the buildup of a fatty substance called plaque. Learn about the risks and prevention.
More about Atherosclerosis on MedlinePlus
Atherosclerosis trials in other cities
- Boston, MA10 studies
- Houston, TX10 studies
- Washington, DC9 studies
- Arlington, VA8 studies
- Hialeah, FL8 studies
- Orlando, FL8 studies
- Miami, FL7 studies
- Memphis, TN7 studies
- Durham, NC7 studies
- Las Vegas, NV7 studies
- Dallas, TX7 studies
- Omaha, NE6 studies
Other studies in Topeka
- Overweight7 studies
- Steatotic Liver Disease7 studies
- Non-Small Cell Lung Cancer7 studies
- Prostate Cancer7 studies
- Breast Cancer6 studies
- Obesity6 studies
- Crohn's Disease6 studies
- Lung Cancer6 studies
- Cardiovascular Disease5 studies
- Melanoma4 studies
- Esophageal Cancer4 studies
- Bladder Cancer4 studies
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.